Abstract
Dear Readers,The German Journal of Pharmaceuticals and Biomaterials (GJPB) is a new journal published in Germany that focuses on Pharmaceutical Sciences and Biomaterials. This journal is neither beholden to commercial interests nor a scientific organisation and is, therefore, free to respond to the demands of writers and readers and offers a genuinely cost-effective publication service. GJPB is a quarterly publication covering all disciplines linked to Pharmaceutical Sciences and Biomaterials. It appeals to both specialised and multidisciplinary interests. The journal publishes research papers and reviews the current state of the art in Pharmaceutical Sciences and Biomaterials. Articles on Pharmaceutical/Biomaterial research, teaching & learning, laboratory innovations, education technology, and other related topics will be presented. Fair and open review methods for acceptability and a double-blind refereeing system are other significant elements of GJPB. The publication of the journal is free of charge. It is an excellent opportunity to try out this journal and take advantage of free publication. The papers will be evaluated by the Editorial Board and a vast panel of reviewers. Members of the Editorial Board and reviewer panel are recruited worldwide and have expertise in Pharmaceutical Sciences and Biomaterials. I guarantee a timely, courteous, and unbiased review of your paper based on clearly defined acceptable standards. I am glad to extend a warm welcome to you at the inauguration of the "German Journal ofPharmaceuticals and Biomaterials". I want to express my gratitude to the entire team, as they are the backbone of this scientific endeavour.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: German Journal of Pharmaceuticals and Biomaterials
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
